Clinical Trial: Real-World Study of Intravitreal Aflibercept 8 mg in Pretreated Eyes With nAMD or DME

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07761039) titled 'Real-World Study of Intravitreal Aflibercept 8 mg in Pretreated Eyes With nAMD or DME' on Aug. 07.

Brief Summary: The goal of this multicentre observational study is to evaluate the interval-extension potential, effectiveness, and safety of intravitreal aflibercept 8 mg in pretreated eyes with neovascular age-related macular degeneration (nAMD) or diabetic macular oedema (DME) under routine clinical practice in Portugal.

It consists in an ambidirectional longitudinal cohort with retrospective collection of pre-switch clinical and treatment history and prospective follow-up after initiation of intravitreal aflibercept 8 mg in routin...